Clinical trial
The Efficacy and Safety Assessment of Huafu Shengji Ointment in Patients With Diabetic Foot of Qi Deficiency and Blood Stasis Syndrome: A Study Protocol for a Randomized Controlled Trial
NCT06487117 is registered in ClinicalTrials.gov with Beijing Daxing District Hospital of Integrated Chinese and Western Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety Assessment of Huafu Shengji Ointment in Patients With Diabetic Foot of Qi Deficiency and Blood Stasis Syndrome: A Study Protocol for a Randomized Controlled Trial
- Lead sponsor
- Beijing Daxing District Hospital of Integrated Chinese and Western Medicine
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- September 30, 2024
- Completion date
- December 31, 2025
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.